A prospective multicentre controlled study of Gaoweikang (Chinese multiherb extract-based tincture) used in high-risk HPV infections.

医学 内科学 B组 前瞻性队列研究 酊剂(纹章学) 胃肠病学 外科 传统医学
作者
Chen Lm,Cong Qi,Deqing Wu,Pei‐Jer Chen,Lugui Qiu,Zhi-Jie Hong,Ying Yang,Xu Liu,Wang Lf,Li Huang,W-R Li,Jiyu Tang,Yongli Cao,Lu-Lu Sui
出处
期刊:PubMed [National Institutes of Health]
卷期号:27 (19): 8985-8992
标识
DOI:10.26355/eurrev_202310_33922
摘要

The aim of the study was to investigate the safety and antiviral efficacy of a Chinese multiherb extract-based tincture (GWK) on a population of patients with high-risk human papilloma (hrHPV) infections and hrHPV-caused cervical low-grade squamous intraepithelial lesions (LSILs).Patients with persistent hrHPV infection were enrolled in Group A, including A1 subjects, who received the intervention, and A2 subjects, who received the control. Patients with hrHPV infection causing cervical LSIL were enrolled in Group B, which included B1 subjects, who received the intervention, and B2 subjects, who served as the control. For Groups A1 and B1, hrHPV was tested at 3 months (M3) and 6 months (M6) after the intervention. The side effects were also analyzed.At baseline (D0), a total of 99 patients were enrolled in Group A, with 50 subjects in Group A1 and 49 subjects in Group A2. A total of 91 patients were enrolled in Group B, with 45 subjects in Group B1 and 46 subjects in Group B2. There was no significant difference in the characteristics, including average age, age stratification, and HPV genotype. At M6, both Group A1 and Group B1 had a higher hrHPV clearance rate than the control group (A1/A2: 80.0% vs. 20.4%; B1/B2: 64.4% vs. 15.2%, p<0.001). At M6, the effective rates of Group A1 and Group B1 were 84% (42/50) and 68.9% (31/45), respectively. The side effect rates of Groups A1 and B1 were 11.5% (6/52) and 11.1% (5/45), respectively. Most adverse reactions involved local discomfort, including vulvar erythema, vulvar itch, increased vaginal discharge, cervical bleeding, and mild pain in the lower abdomen. Univariate logistic regression analysis showed that the intervention had an OR of 12 (95% CI 4.431-32.50) for clearing persistent HPV infection (p<0.001). For cervical LSIL, the intervention had an OR of 10.1 for clearing persistent HPV infection (95% CI 3.68-27.7) (p<0.001).The results of this study suggest that the Chinese multiherb extract-based tincture GWK is safe and well tolerated. Furthermore, this preliminary study showed that this Chinese multiherb extract-based tincture is helpful for promoting HPV clearance in cases of persistent HPV and HPV-induced LSIL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
好名字完成签到,获得积分10
1秒前
DAY1发布了新的文献求助10
1秒前
ccc完成签到,获得积分10
1秒前
2秒前
2秒前
bianco2007发布了新的文献求助10
2秒前
cucumber完成签到,获得积分10
5秒前
Copyright应助等待黎云采纳,获得10
5秒前
6秒前
来了完成签到,获得积分10
7秒前
8秒前
chen完成签到 ,获得积分10
9秒前
9秒前
豆子发布了新的文献求助10
9秒前
song发布了新的文献求助10
10秒前
dqbhxwx完成签到,获得积分10
10秒前
12秒前
12秒前
cmx发布了新的文献求助10
12秒前
刘丽红发布了新的文献求助10
12秒前
研友_VZG7GZ应助白术采纳,获得10
13秒前
论文仙人兔一乐完成签到,获得积分10
14秒前
yu_z发布了新的文献求助30
14秒前
檀小完成签到,获得积分10
14秒前
抗抗完成签到,获得积分10
14秒前
xiamo完成签到,获得积分10
14秒前
15秒前
美满的苠发布了新的文献求助10
15秒前
科研通AI6.3应助DAY1采纳,获得10
16秒前
苦行者发布了新的文献求助10
16秒前
XXX发布了新的文献求助10
17秒前
17秒前
17秒前
典雅碧空发布了新的文献求助10
18秒前
可可西里完成签到 ,获得积分10
18秒前
yuze发布了新的文献求助10
19秒前
非衣儿应助文龙之子采纳,获得10
19秒前
123发布了新的文献求助10
21秒前
hobi完成签到 ,获得积分10
22秒前
彭于晏应助斯文念双采纳,获得10
23秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Molecular Mechanisms of Photosynthesis, 4th Edition 1000
Organic Reactions, Volume 116 1000
Current concepts in cutaneous toxicity : proceedings of the Fourth Conference on Cutaneous Toxicity, Washington, D.C., May 9-11, 1979 1000
The recovery-stress questionnaires : user manual 800
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7259569
求助须知:如何正确求助?哪些是违规求助? 8881545
关于积分的说明 18766422
捐赠科研通 6939683
什么是DOI,文献DOI怎么找? 3201633
关于科研通互助平台的介绍 2375437
邀请新用户注册赠送积分活动 2177387